The treatment effect of diazoxide on 44 patients with congenital hyperinsulinism

Journal of Pediatric Endocrinology and Metabolism

Volumn 25, Issue 11-12, 2012, Pages 1119-1122

  Hu, Shuwen ^a   Xu, Zidi ^a   Yan, Jie ^a   Liu, Min ^a   Sun, Bing ^a   Li, Wenjing ^a   Sang, Yanmei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Congenital hyperinsulinism; Diazoxide; Side effect

Indexed keywords

DIAZOXIDE; GLUCOSE; HYDROCHLOROTHIAZIDE;

ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRICHOSIS; INFANT; MALE; NEWBORN; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRESCHOOL CHILD; SIDE EFFECT;

AGE OF ONSET; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; CHINA; CONGENITAL HYPERINSULINISM; DIAZOXIDE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; TREATMENT OUTCOME;

EID: 84872935218     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2012-0224     Document Type: Article

References (15)

1. Arnoux JB, de Lonlay P, Ribeiro MJ, Hussain K, Blankenstein O, et al. Congenital hyperinsulinism. Early Hum Dev 2010;86: 287-94.
2. Fajans SS, Bell GI. Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4alpha (HNF4A). Diabetologia 2007;50:2600-1.
3. Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, et al. Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr 2001;38:383-9.
4. Sayed S, Langdon DR, Odili S, Chen P, Buettger C, et al. Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations. Diabetes 2009;58:1419-27.
5. Hussain K. Diagnosis and management of hyperinsulinaemic hypoglycaemia of infancy. Horm Res 2008;69:2-13.
6. Hussain K, Aynsley- Green A, Stanley CA. Medications used in the treatment of hypoglycemia due to congenital hyperin sulinism of infancy (HI) Pediatr Endocrinol Rev 2004;2 (Suppl. 1):163-7.
7. De Leon DD, Stanley CA. Mechanism of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab 2007;3:57-68.
8. Bruining GJ. Recent advances in hyperinsulinism and pathogenesis of diabetes mellitus. Curr Opin Pediatr 1990;2:758-65.
9. Martens GA, Vervoort A, Van de CM, Stangé G, Hellemans K, et al. Specificity in beta cell expression of L-3-hydroxyacyl-CoA dehydrogenase, short chain, and potential role in down-regulating insulin release. J Biol Chem 2007;282:21134-44.
10. Cuesta-Munoz AL, Huopio H, Otonkoski T, Gomez-Zumaquero JM, Nanto-Salonen K, et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes 2004;53:2164-8.
11. Otonkoski T, Jiao H, Kaminen-Ahola N, Tapia-Paez I, Ullah MS, et al. Physical exercise induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells. Am J Hum Genet 2007;81:467-74.
12. Touati G, Poggi-Travert F, Ogier de BH, Rahier J, Brunelle F, et al. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr 1998;157:628-33.
13. Meissner T, Wendel U, Burgard P, Schaetzle S, Mayatepek E, et al. Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur J Endocrinol 2003;149:43-51.
14. Mazor-Aronovitch K, Gillis D, Lobel D, Hirsch HJ, Pinhas-Hamiel O. Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism. Eur J Endocrinol 2007;157:491-7.
15. Hussain K, Blankenstein O, De Lonlay P, Christesen HT. Hyperinsulinaemic hypoglycemia: biochemical basis and the importance of maintaining normoglycaemia during management. Arch Dis Child 2007;92:568-70.